Works matching IS 10870156 AND DT 2012 AND VI 30 AND IP 2
Results: 45
Drug partners for antibiotics.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 2, p. 158, doi. 10.1038/nbt.2131
- By:
- Publication type:
- Article
In this issue.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 2, p. vii, doi. 10.1038/nbt.2132
- Publication type:
- Article
Corrigendum: Intellectual property, technology transfer and manufacture of low-cost HPV vaccines in India.
- Published in:
- 2012
- By:
- Publication type:
- Correction Notice
Ablynx drops lead nanobody.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 2, p. 124, doi. 10.1038/nbt0212-124a
- By:
- Publication type:
- Article
Generation of human vascular smooth muscle subtypes provides insight into embryological origin-dependent disease susceptibility.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 2, p. 165, doi. 10.1038/nbt.2107
- By:
- Publication type:
- Article
Gilead's $11 billion HCV bet.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 2, p. 122, doi. 10.1038/nbt0212-122a
- By:
- Publication type:
- Article
Personal medicine-the new banking crisis.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 2, p. 141, doi. 10.1038/nbt.2116
- By:
- Publication type:
- Article
Genome sequencing reveals agronomically important loci in rice using MutMap.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 2, p. 174, doi. 10.1038/nbt.2095
- By:
- Publication type:
- Article
Around the world in a month.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 2, p. 126, doi. 10.1038/nbt0212-126b
- Publication type:
- Article
2011-Big biotechs gorge on debt.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 2, p. 127, doi. 10.1038/nbt.2119
- By:
- Publication type:
- Article
True colors of genome variation.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 2, p. 158, doi. 10.1038/nbt.2128
- By:
- Publication type:
- Article
Three-dimensional reconstruction of protein networks provides insight into human genetic disease.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 2, p. 159, doi. 10.1038/nbt.2106
- By:
- Publication type:
- Article
Amyloid disease drug approved.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 2, p. 121, doi. 10.1038/nbt0212-121b
- By:
- Publication type:
- Article
Gap junction inhibition prevents drug-induced liver toxicity and fulminant hepatic failure.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 2, p. 179, doi. 10.1038/nbt.2089
- By:
- Publication type:
- Article
Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugates.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 2, p. 184, doi. 10.1038/nbt.2108
- By:
- Publication type:
- Article
Sangamo's lead zinc-finger therapy flops in diabetic neuropathy.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 2, p. 121, doi. 10.1038/nbt0212-121a
- By:
- Publication type:
- Article
Fourth-quarter biotech job picture.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 2, p. 195, doi. 10.1038/nbt.2123
- By:
- Publication type:
- Article
Enbrel patent surfaces.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 2, p. 123, doi. 10.1038/nbt0212-123
- By:
- Publication type:
- Article
Toll-like receptor blocker slows beta cell death in type 1 diabetes.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 2, p. 124, doi. 10.1038/nbt0212-124c
- By:
- Publication type:
- Article
Corrigendum: Chinese vaccine developers gain WHO imprimatur.
- Published in:
- 2012
- By:
- Publication type:
- Correction Notice
Affymetrix sued for fraud.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 2, p. 122, doi. 10.1038/nbt0212-122b
- By:
- Publication type:
- Article
PRIDE Inspector: a tool to visualize and validate MS proteomics data.
- Published in:
- 2012
- By:
- Publication type:
- Letter
Corrigendum: Industry continues dabbling with open innovation models.
- Published in:
- 2012
- By:
- Publication type:
- Correction Notice
People.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 2, p. 196, doi. 10.1038/nbt.2124
- Publication type:
- Article
Fresh from the biotech pipeline 2011.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 2, p. 128, doi. 10.1038/nbt.2111
- By:
- Publication type:
- Article
Improving glycoconjugate vaccines.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 2, p. 158, doi. 10.1038/nbt.2129
- By:
- Publication type:
- Article
Planning for the exit.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 2, p. 132, doi. 10.1038/nbt.2093
- By:
- Publication type:
- Article
Corrigendum: FDA panel votes to pull Avastin in breast cancer, again.
- Published in:
- 2012
- By:
- Publication type:
- Correction Notice
Erratum: Amelioration of sepsis by inhibiting sialidase-mediated disruption of the CD24-SiglecG interaction.
- Published in:
- 2012
- By:
- Publication type:
- Correction Notice
Why genies don't go back into bottles.
- Published in:
- 2012
- Publication type:
- Editorial
Erratum: Factors influencing agbiotech adoption and development in sub-Saharan Africa.
- Published in:
- 2012
- By:
- Publication type:
- Correction Notice
Recent patent applications related to stem cells.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 2, p. 151, doi. 10.1038/nbt.2125
- Publication type:
- Article
Funding and performance at the US Patent and Trademark Office.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 2, p. 148, doi. 10.1038/nbt.2110
- By:
- Publication type:
- Article
Big pharma upheavals cast shadow across biotech sector.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 2, p. 119, doi. 10.1038/nbt0212-119
- By:
- Publication type:
- Article
Smooth muscle diversity from human pluripotent cells.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 2, p. 152, doi. 10.1038/nbt.2117
- By:
- Publication type:
- Article
Mapping chromatin regulators.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 2, p. 158, doi. 10.1038/nbt.2130
- By:
- Publication type:
- Article
The blinded buyer.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 2, p. 139, doi. 10.1038/nbt.2094
- By:
- Publication type:
- Article
India's innovation czar.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 2, p. 124, doi. 10.1038/nbt0212-124b
- By:
- Publication type:
- Article
Complex binding sites made to order.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 2, p. 154, doi. 10.1038/nbt.2118
- By:
- Publication type:
- Article
UK government unveils innovation booster.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 2, p. 125, doi. 10.1038/nbt0212-125
- By:
- Publication type:
- Article
Gene-based passive antibody protection from HIV.
- Published in:
- 2012
- By:
- Publication type:
- Opinion
Increased Diels-Alderase activity through backbone remodeling guided by Foldit players.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 2, p. 190, doi. 10.1038/nbt.2109
- By:
- Publication type:
- Article
TAL effector-DNA structure.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 2, p. 158, doi. 10.1038/nbt.2127
- By:
- Publication type:
- Article
OpenVigil-free eyeballs on AERS pharmacovigilance data.
- Published in:
- 2012
- By:
- Publication type:
- Letter
Life Technologies promises $1,000 genome.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 2, p. 126, doi. 10.1038/nbt0212-126a
- By:
- Publication type:
- Article